Report cover image

Alzheimer Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Publisher GlobalData
Published Nov 29, 2022
Length 324 Pages
SKU # GBDT17577145

Description

Alzheimer Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Summary

GlobalData's Medical Devices sector report, “Alzheimer Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Alzheimer pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Alzheimer is a progressive neurologic disorder beginning with mild memory loss and possibly leading to loss of the ability to carry on a conversation and respond to the environment.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Alzheimer under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Alzheimer and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Alzheimer under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

324 Pages
  • About GlobalData
    • Alzheimer Overview
    • Alzheimer - Pipeline Products by Stage of Development
    • Alzheimer - Pipeline Products by Territory
    • Alzheimer - Pipeline Products by Regulatory Path
    • Alzheimer - Pipeline Products by Estimated Approval Date
    • Alzheimer - Ongoing Clinical Trials
    • Alzheimer Companies - Pipeline Products by Stage of Development
    • Alzheimer - Companies Pipeline Products by Stage of Development
    • 5M Biomed LLC Company Overview
    • AC Immune SA Company Overview
    • Acobiom Company Overview
    • Acumen Pharmaceuticals Inc Company Overview
    • Adlyfe Inc Company Overview
    • Admit Therapeutics SL Company Overview
    • ADx NeuroSciences NV Company Overview
    • Aelan Cell Technologies Company Overview
    • Agent Biotech Company Overview
    • Albert Ludwigs University of Freiburg Company Overview
    • Alere Inc Company Overview
    • AltPep Corp Company Overview
    • Alzheon Inc Company Overview
    • Alzhyme Pty Ltd Company Overview
    • Alzinova AB Company Overview
    • Amarantus Bioscience Holdings Inc Company Overview
    • Amarantus Diagnostics Inc Company Overview
    • Ambergen Inc Company Overview
    • Amco International Manufacturing Inc. Company Overview
    • Amoneta Diagnostics SAS Company Overview
    • Amprion Inc Company Overview
    • Applied NeuroSolutions, Inc. (Inactive) Company Overview
    • Arkley Biotek LLC Company Overview
    • Ascent Bio-Nano Technologies Inc Company Overview
    • attyloid GmbH Company Overview
    • Banyan Biomarkers Inc Company Overview
    • Beaumont Health System Company Overview
    • BioArctic AB Company Overview
    • Bioasis Technologies Inc Company Overview
    • Biocross SL Company Overview
    • Biois Corp Company Overview
    • Biomedical Development Corp Company Overview
    • BioSystems International Company Overview
    • Boston University Medical Campus Company Overview
    • Brigham and Women's Hospital Company Overview
    • C2N Diagnostics LLC Company Overview
    • Calviri Inc Company Overview
    • Cassava Sciences Inc Company Overview
    • Cayman Chemical Co Company Overview
    • Chronix Biomedical Inc Company Overview
    • Cleveland Diagnostics Inc. Company Overview
    • Cognext Diagnostics LLC Company Overview
    • Columbia University Company Overview
    • Cx Precision Medicine Inc Company Overview
    • Cymedx Company Overview
    • Cytox Ltd Company Overview
    • Diadem SRL Company Overview
    • DiamiR LLC Company Overview
    • DiaPat GmbH Company Overview
    • Durin Technologies, Inc. Company Overview
    • Early Alzheimer's Diagnostics LLC Company Overview
    • Emory University Company Overview
    • Eurobio Scientific SA Company Overview
    • Florida Institute of Technology Company Overview
    • French National Institute of Health and Medical Research Company Overview
    • Fujirebio Diagnostics Inc Company Overview
    • GenoScreen SAS Company Overview
    • Ghent University Company Overview
    • IBM Research-Australia Company Overview
    • ICDD-sas Company Overview
    • Inbiomed Company Overview
    • Innovative Health Diagnostics Company Overview
    • Inscopix Inc Company Overview
    • Instituto de Estructura de la Materia Company Overview
    • Integrated Diagnostics Inc (Inactive) Company Overview
    • Intelligent OMICS Ltd Company Overview
    • Janssen Pharmaceutica NV Company Overview
    • Johns Hopkins University Company Overview
    • Johns Hopkins University School of Medicine Company Overview
    • KineMed Inc Company Overview
    • King's College London Company Overview
    • Lund University Company Overview
    • McGill University Health Center Company Overview
    • Medifron DBT Inc Company Overview
    • Memory Dx LLC Company Overview
    • Meso Scale Diagnostics LLC Company Overview
    • Metabolon Inc Company Overview
    • Michigan State University Company Overview
    • MYND Diagnostics Ltd Company Overview
    • Myriad RBM Inc Company Overview
    • NanoSomiX Inc Company Overview
    • Nanosphere Inc (Inactive) Company Overview
    • National Research Foundation of Korea Company Overview
    • National University of Singapore Company Overview
    • Navotavo Inc Company Overview
    • Nel ASA Company Overview
    • NeoNeuro SAS Company Overview
    • Neuro Bio Ltd Company Overview
    • NeuroQuest Ltd Company Overview
    • NeuroVision Imaging LLC Company Overview
    • Newcastle University Company Overview
    • Novel Bio-spectrum Technologies Inc (Inactive) Company Overview
    • Numares AG Company Overview
    • Oligomerix inc Company Overview
    • Orasi Medical, Inc. (Inactive) Company Overview
    • Oryzon Genomics SA Company Overview
    • Peri Rx Inc Company Overview
    • Pre Diagnostics AS Company Overview
    • Predemtec GmbH Company Overview
    • ProMIS Neurosciences Inc Company Overview
    • Proplex Technologies Llc Company Overview
    • Protagen AG Company Overview
    • Proteome Sciences Plc Company Overview
    • Proteomics International Laboratories Ltd Company Overview
    • Quanterix Corp Company Overview
    • Redox Diagnostics LLC Company Overview
    • Roche Diagnostics GmbH Company Overview
    • Roche Diagnostics International Ltd Company Overview
    • Rockefeller University Company Overview
    • Ruhr-University Bochum Company Overview
    • Scanogen Inc Company Overview
    • Scout Diagnostics LLC Company Overview
    • Seer Biosciences Inc Company Overview
    • Siemens Healthineers AG Company Overview
    • Spanish National Research Council Company Overview
    • StageZero Life Sciences Ltd Company Overview
    • Sugentech Inc Company Overview
    • Synaptogenix, Inc. Company Overview
    • TauRx Pharmaceuticals Ltd Company Overview
    • Telo Genomics Corp Company Overview
    • The Florey Institute of Neuroscience and Mental Health Company Overview
    • The Hong Kong University of Science and Technology Company Overview
    • The University of Nottingham Company Overview
    • Todos Medical Company Overview
    • TopoGEN Inc Company Overview
    • Trinity College Dublin Company Overview
    • University of Calgary Company Overview
    • University of California San Francisco Company Overview
    • University of Chicago Company Overview
    • University of Georgia Company Overview
    • University of Gottingen Company Overview
    • University of Illinois at Chicago Company Overview
    • University of Luxembourg Company Overview
    • University of Maryland Baltimore Company Overview
    • University of Melbourne Company Overview
    • University of Oxford Company Overview
    • University of Pittsburgh Company Overview
    • University of South Carolina Company Overview
    • University of South Florida Company Overview
    • University of Texas Health Science Center at Houston Company Overview
    • University of Texas Southwestern Medical Center Company Overview
    • Urvogelbio Pvt Ltd Company Overview
    • US Biomarkers Inc Company Overview
    • vall d hebron institut de Recerca Company Overview
    • Veravas Inc Company Overview
    • Virtici LLC Company Overview
    • Vitruvian Biomedical Inc Company Overview
    • Washington University in St Louis Company Overview
    • Washington University School of Medicine Company Overview
    • WellSIM Biomedical Technologies Inc Company Overview
    • Zoiray Technologies Inc. Company Overview
    • Nov 16, 2022: InMed Pharmaceuticals Advances Neurodegenerative Disease Program with Natural Sciences and Engineering Research Council of Canada ("NSERC") Alliance Grant Funding
    • Nov 15, 2022: StageZero Life Sciences Announces Q3 2022 Financial Results and Operational Update
    • Nov 14, 2022: BioArctic receives new patent in the US for blood-brain barrier transport technology
    • Nov 14, 2022: ProMIS Neurosciences Announces Third Quarter 2022 Financial Results and Recent Highlights
    • Nov 11, 2022: StageZero to Hold Q3 2022 Operational and Financial Results Conference Call on Tuesday November 15, 2022
    • Nov 10, 2022: Amylyx Pharmaceuticals Reports Third Quarter 2022 Financial Results
    • Nov 09, 2022: Keystone Bio Adds Significant Scientific Leadership with Appointment of Medical Advisor and New Scientific Advisory Board Members
    • Nov 03, 2022: Amylyx Pharmaceuticals to Report Third Quarter 2022 Financial Results on November 10, 2022
    • Nov 01, 2022: Aspira Women's Health to Announce Third Quarter 2022 Financial Results and Host Conference Call on Thursday, November 10
    • Oct 31, 2022: Myriad Genetics Expands Board of Directors with Election of Paul M. Bisaro as New Board Member
    • Oct 26, 2022: URI neuroscientist receives $10.3 million grant for research on retinal scanning to detect early-stage Alzheimer's
    • Oct 11, 2022: $9 million to fund study of `jumping genes' in Alzheimer's
    • Oct 06, 2022: Pfizer appoints Deb Mangone as Ireland country manager
    • Oct 04, 2022: Study of Alzheimer's patients launched in bid to find early test
    • Sep 20, 2022: Pfizer Invites Public to View and Listen to Webcast of November 1 Conference Call with Analysts
    • Sep 06, 2022: Labcorp to Speak at the Baird 2022 Global Healthcare Conference
    • Sep 06, 2022: Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
    • Aug 31, 2022: Bristol Myers Squibb to Participate in Citi's 17th Annual BioPharma Conference
    • Aug 31, 2022: Pfizer lures first chief marketing officer from Verily
    • Aug 30, 2022: Cortechs.ai Awarded Million Dollar NIH Grant for Early Diagnosis of Alzheimer's Disease Using Advanced Diffusion MRI Technique
    • Aug 24, 2022: Blood test detects Alzheimer's in people with Down syndrome
    • Aug 19, 2022: Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
    • Aug 17, 2022: Mytide Therapeutics partners with Agilent to collaborate on automation solutions for Mytide's next-generation manufacturing platform
    • Aug 16, 2022: StageZero Life Sciences Announces second quarter financial results for the three months ended June 30, 2022
    • Aug 12, 2022: StageZero to Hold Q2 2022 Operational and Financial Results Conference Call on Tuesday August 16, 2022
    • Aug 11, 2022: Amylyx Pharmaceuticals Reports Second Quarter 2022 Financial Results
    • Aug 08, 2022: Research from Beacon Biosignals presented at Alzheimer's Association International Conference
    • Aug 08, 2022: UNH awarded $2.8 million to develop robots to care for people with Alzheimer's and Dementia
    • Aug 05, 2022: Researchers gain insights into the genetic and molecular machinery that predisposes individuals to Alzheimer's Disease
    • Aug 05, 2022: Synaptogenix Announces Quarterly Report For the quarterly period ended June 30, 2022
    • Jul 28, 2022: AC Immune Reports Second Quarter 2022 Financial Results and Provides Corporate Update
    • Jul 28, 2022: Merck Announces Second-Quarter 2022 Financial Results
    • Jul 28, 2022: Labcorp Announces 2022 Second Quarter Results
    • Jul 28, 2022: Montefiore awarded $2.3 million to care for people with memory disorders in the Hudson Valley
    • Jul 22, 2022: ORYZON Reports Results and Corporate Update for Half-Year Ending June 30, 2022
    • Jul 12, 2022: Aspire & USF Pass $10M in ticket & donation revenue
    • Jul 05, 2022: ORYZON Announces a New Financing Through a Convertible Bond Program for a Total Amount up to 20 Million Over 30 Months
    • Jun 24, 2022: Pfizer Invites Public to View and Listen to Webcast of July 28 Conference Call with Analysts
    • Jun 15, 2022: Bioasis Announces Filing of Its Fourth Quarter and Fiscal Year-End Financial Statements and MD&A
    • Jun 09, 2022: Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
    • Jun 09, 2022: Myriad Genetics CEO Paul Diaz to Speak at Goldman Sachs 43rd Annual Global Healthcare Conference
    • Jun 07, 2022: Molecular Stethoscope, announces new investment from the Alzheimer's Drug Discovery Foundation
    • Jun 01, 2022: Agilent releases IVDR-compliant instruments, kits, and reagents for use in the European Union
    • May 26, 2022: Bristol Myers Squibb to Participate in Bernstein's 38th Annual Strategic Decisions Conference
    • May 25, 2022: Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
    • May 19, 2022: C2N introduces new test to aid Alzheimer's diagnosis
    • May 17, 2022: Labcorp to Speak at the UBS 2022 Global Healthcare Conference
    • May 13, 2022: ProMIS Neurosciences Announces First Quarter 2022 Results
    • May 13, 2022: StageZero Life Sciences Announces annual and special meeting
    • May 05, 2022: ORYZON Reports Results and Corporate Update for Quarter Ended March 31, 2022
    • May 04, 2022: Luminex announces upcoming initial public offering
    • May 04, 2022: Labcorp to Webcast Its Annual Meeting of Shareholders
    • May 04, 2022: Myriad Genetics CEO Paul Diaz to Speak at Bank of America Securities 2022 Healthcare Conference
    • May 03, 2022: Pfizer Reports First quarter 2022 Results
    • Apr 28, 2022: Merck Announces First-Quarter 2022 Financial Results
    • Apr 28, 2022: AC Immune Reports First Quarter 2022 Financial Results and Provides Corporate Update
    • Apr 27, 2022: Zentalis Pharmaceuticals Announces $25 Million Equity Investment from Pfizer
    • Apr 26, 2022: New $4.2 Million NIH grant to discover novel markers of early Alzheimer's Disease
    • Apr 20, 2022: BioArctic's Invitation to presentation First Quarter Report for January - March 2022 on April 28 at 9.30 a.m. CET
    • Apr 20, 2022: Invitation to presentation of BioArctic's First Quarter Report for January - March 2022 on April 28 at 9.30 a.m. CET
    • Apr 19, 2022: Pfizer Invites Shareholders to Attend Virtual-Only 2022 Annual Meeting of Shareholders on April 28
    • Apr 14, 2022: TauRx's late-stage clinical trial reaches new milestone
    • Apr 06, 2022: StageZero Life Sciences announces corporate update
    • Mar 29, 2022: Synaptogenix to Present at Hanson Wade 10th Annual Neurodegenerative Drug Development Summit
    • Mar 28, 2022: ORYZON Announces Appointment of Douglas V. Faller, MD, PhD as Global Chief Medical Officer and Continues its Expansion of US Corporate Activities
    • Mar 22, 2022: AC Immune Reports Full Year 2021 Financial Results and Provides Corporate Update
    • Mar 22, 2022: Synaptogenix to Present at Sachs 5th Annual Neuroscience Innovation Forum
    • Mar 17, 2022: ProMIS Neurosciences Announces Fiscal Year 2021 Results
    • Mar 17, 2022: Plasma biomarker screening could improve accuracy, health equity in Alzheimer's disease diagnosis
    • Mar 09, 2022: Bioasis to Attend and Present at Upcoming Industry Conference
    • Feb 28, 2022: Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
    • Feb 28, 2022: Feinstein Institutes' studies show CTE-linked tau protein may contribute to psychosis in Alzheimer's disease
    • Feb 24, 2022: Myriad Genetics Reports Fourth Quarter 2021 Results Provides Updates on Product Performance and Growth Initiatives
    • Feb 23, 2022: Amylyx Pharmaceuticals Expands Executive Team with Appointment of Gina M. Mazzariello as Chief Legal Officer and General Counsel
    • Feb 22, 2022: Agilent Reports First-Quarter Fiscal Year 2022 Financial Results
    • Feb 22, 2022: Aspira Women's Health Expands Senior Leadership Team with Addition of Mr. Michael Newton as Head of Sales and Marketing
    • Feb 14, 2022: Myriad Genetics to Present at Two Upcoming Healthcare Conferences
    • Feb 09, 2022: Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
    • Feb 07, 2022: Altoida partners with GN Group to research and develop new cognitive assessment technology to detect mild cognitive impairment
    • Feb 03, 2022: Merck Announces Fourth-Quarter and Full-Year 2021 Financial Results
    • Feb 03, 2022: ProMIS Neurosciences Appoints Renowned Neuroscientists, Dr. Guy Rouleau and Dr. Alain Dagher to its Scientific Advisory Board
    • Feb 01, 2022: Pfizer Announces New Chief Development Officer
    • Jan 27, 2022: Cognito Therapeutics and Providence Health Plan launch phase 3 study to evaluate disease-modifying therapeutic in mild cognitive impairment
    • Jan 27, 2022: New drug screening method answers why Alzheimer's drugs fail, suggests new targets
    • Jan 25, 2022: Oxford BioDynamics announces Final Results
    • Jan 04, 2022: Bristol Myers Squibb to Present at J.P. Morgan's 40th Annual Healthcare Conference
    • Jan 04, 2022: Myriad Genetics Chief Scientific Officer Jerry Lanchbury Retires after 19 Years of Service
    • Jan 04, 2022: Labcorp to Speak Virtually at the 40th Annual J.P. Morgan Healthcare Conference
    • Dec 30, 2021: Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
    • Dec 17, 2021: Bristol Myers Squibb to Report Results for Fourth Quarter 2021 on February 4 2022
    • Dec 15, 2021: Alzheimer's test provides much needed answers to patients and their families
    • Nov 29, 2021: Bioasis Announces Annual General Meeting Details
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.